Comment on

• Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157.

  Stavrinides V, Giganti F, Punwani S, Allen C, Kirkham A, Freeman A, Ball R, Haider A, Whitaker H, Orczyk C, Emberton M, Moore CM. Stavrinides V, et al. J Urol. 2020 Nov;204(5):1065-1066. doi: 10.1097/JU.0000000000001295. Epub 2020 Jul 23. J Urol. 2020. PMID: 32698715 No abstract available.